logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
SGP
SpyGlass Pharma, Inc. Common Stock
24.85
1 x 21.88
1 x 24.73
bid
ask
-
0.31
1.23%
1 @ 04:00 PM
24.85 +0.00 (0.00%)
Ytd-5.87%
1y-5.87%
24.50
day range
25.58
17.06
52 week range
32.44
Open25.17Prev Close25.16Low24.50High25.58Mkt Cap830.82M
Vol0.00Avg Vol111.26KEPS-6.41P/E-3.88Forward P/EN/A
BetaN/AShort RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg20.38200-d Avg23.141yr Est0.00

SGP News

SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL Sys

Spyglass Pharma (NASDAQ:SGP) Shares Gap Up – Still a Buy?
defenseworld.net
Spyglass Pharma (NASDAQ:SGP) Shares Gap Up – Still a Buy?

Spyglass Pharma, Inc. (NASDAQ: SGP - Get Free Report)'s stock price gapped up prior to trading on Fr

Affinity Asset Advisors LLC Buys Shares of 250,000 Spyglass Pharma, Inc. $SGP
defenseworld.net
Affinity Asset Advisors LLC Buys Shares of 250,000 Spyglass Pharma, Inc. $SGP

Affinity Asset Advisors LLC purchased a new position in shares of Spyglass Pharma, Inc. (NASDAQ: SGP

SpyGlass Pharma Appoints Shannon Treviño as General Counsel
globenewswire.com
SpyGlass Pharma Appoints Shannon Treviño as General Counsel

ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
globenewswire.com
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass

SpyGlass Pharma to Participate in Upcoming Investor Conferences
globenewswire.com
SpyGlass Pharma to Participate in Upcoming Investor Conferences

ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass

SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
globenewswire.com
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

ALISO VIEJO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass

SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

ALISO VIEJO, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass

Analyzing Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP)
defenseworld.net
Analyzing Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP)

Spyglass Pharma (NASDAQ: SGP - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report

SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
globenewswire.com
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

ALISO VIEJO, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGla

Comparing Spyglass Pharma (NASDAQ:SGP) & Nanovibronix (NASDAQ:FEED)
defenseworld.net
Comparing Spyglass Pharma (NASDAQ:SGP) & Nanovibronix (NASDAQ:FEED)

Nanovibronix (NASDAQ: FEED - Get Free Report) and Spyglass Pharma (NASDAQ: SGP - Get Free Report) ar

Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) Financial Comparison
defenseworld.net
Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) Financial Comparison

Spyglass Pharma (NASDAQ: SGP - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report

SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
globenewswire.com
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-I

ALISO VIEJO, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlas

SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
globenewswire.com
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit

ALISO VIEJO, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGla

3 Macro Charts That Matter Now: U.S. Dollar, Gold, S&P 500
barrons.com
3 Macro Charts That Matter Now: U.S. Dollar, Gold, S&P 500

Middle East tensions are wreaking havoc, with traditional safe havens not providing much protection.

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
benzinga.com
This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Wall Street analysts changed ratings on top companies. See full list at benzinga.com/analyst-stock-r

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More
247wallst.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mo

Pre-Market Stock Futures: Futures are down big as oil shoots higher on Tuesday. After a big early mo

Reddit, KKR, and 2 Biotech IPOs Seeing the Love From Insiders
247wallst.com
Reddit, KKR, and 2 Biotech IPOs Seeing the Love From Insiders

Four stocks seeing the most notable insider purchases in the past week or so were biotechs SpyGlass